title: Eosinophil-derived neurotoxin: a novel biomarker for diagnosis and monitoring of asthma.
abstract: Asthma is associated with increased levels of eosinophils in tissues, body fluids, and bone marrow. Elevated levels of eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP) have been noted in asthma patients. Higher levels of EDN and ECP are also associated with exacerbated asthmatic conditions. Thus, EDN, along with ECP, may aid the diagnosis and monitoring of asthma. Several groups have suggested that EDN is more useful than ECP in evaluating disease severity. This may partially be because of the recoverability of EDN (not sticky, 100% recovery rate), as ECP is a sticky and more highly charged protein. In terms of clinical utility, EDN level is a more accurate biomarker than ECP when analyzing the underlying pathophysiology of asthma. As a monitoring tool, EDN has shown good results in children with asthma as well as other allergic diseases. In children too young to fully participate in lung function tests, EDN levels may be useful as an alter native measurement of eosinophilic inflammation. EDN can also be used in adult patients and in multiple specimen types (e.g., serum, sputum, bronchoalveolar lavage fluid, and nasal lavage fluid). These results are repeatable and reproducible. In conclusion, EDN may be a novel biomarker for the diagnosis, treatment, and monitoring of asthma/allergic disease.
authors: Department of Pediatrics, Asthma & Allergy Center, Inje University Sanggye Paik Hospital, Seoul, Korea.
authors: Chang-Keun
authors: CK
authors: Kim
keywords: Biological markers; Child; Diagnosis; Eosinophil-derived neurotoxin; Monitoring of asthma
references: Am J Respir Crit Care Med. 1998 Jan;157(1):4-9
references: 9445270
references: J Infect Dis. 2002 Nov 1;186(9):1207-11
references: 12402189
references: Allergy. 2004 Jan;59(1):26-32
references: 14674929
references: Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 2):e697-704
references: 20444156
references: J Clin Epidemiol. 1996 Aug;49(8):821-5
references: 8699199
references: Am J Respir Crit Care Med. 2000 Jan;161(1):64-72
references: 10619799
references: Allergol Int. 2007 Dec;56(4):433-8
references: 17965582
references: J Pediatr. 2010 May;156(5):749-54
references: 20171653
references: J Asthma. 2010 Jun;47(5):568-73
references: 20560830
references: J Asthma. 2011 Dec;48(10):994-1000
references: 22022864
references: Clin Exp Allergy. 2008 May;38(5):709-50
references: 18384431
references: Clin Exp Allergy. 1999 Jul;29(7):926-32
references: 10383593
references: Lung. 2007 Mar-Apr;185(2):97-103
references: 17393238
references: Thorax. 2000 Sep;55(9):768-74
references: 10950896
references: Clin Exp Allergy. 1999 Sep;29(9):1172-86
references: 10469025
references: Eur Respir J. 1999 Jan;13(1):15-21
references: 10836317
references: Eur Respir J. 2000 Mar;15(3):486-90
references: 10759441
references: Clin Exp Allergy. 1999 Jun;29(6):786-93
references: 10336595
references: Adv Immunol. 1986;39:177-253
references: 3538819
references: Am J Respir Crit Care Med. 1999 Jun;159(6):1918-24
references: 10351940
references: J Dermatol Sci. 2001 May;26(1):79-82
references: 11323224
references: Clin Exp Allergy. 2001 Jul;31(7):1060-6
references: 11467997